GACAT3 and neoplasm: Knockdown of GACAT3 and overexpression of its relevant miRNA networks suppresses tumor progression, suggesting GACAT3 is a potential therapeutic target (Shen et al., 2016; Zhou et al., 2018; Dong et al., 2020).